Efficacy of ezetimibe for the treatment of non-alcoholic fatty liver disease: A randomized, controlled trial
Not Applicable
- Conditions
- non-alcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000005250
- Lead Sponsor
- Eishiro Mizukoshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Patients will be excluded from the study if they meet any of the following criteria: 1)hepatic virus infections (hepatitis B and C) 2)the current or past consumption of more than 20 g of alcohol daily 3)concurrent hepatocellular carcinoma, as determined by diagnostic imaging results 4) hepatic encephalopathy 5) active infections 6) severe complication 7) Woman who has possibility of pregnancy or pregnancy or while suckling. 8)Case to whom medicine in which it is using together taboo of ezetimibe and describes attention of using together is administered 9) those who are inadequate for this study as assessed by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method